Financials

News Ideas Technicals

LYTIX fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of LYTIX BIOPHARMA AS

Total assets of LYTIX for Q4 23 is 63.44 M NOK, 20.85% less than the previous Q3 23. And total liabilities increased by 7.76% in Q4 23 to 12.06 M NOK.

Q1 '22

Q2 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: NOK

Q1 '22

Q2 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—